证券代码：301220 证券简称：亚香股份 公告编号：2024-035 昆山亚香香料股份有限公司 2023年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无新增、变更及否决议案的情况； 2、本次股东大会不涉及变更以往股东大会已通过决议的情况。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 现场会议时间：2024年5月13日（星期一）14:00。 网络投票时间：通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投 票的具体时间为：2024年5月13日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交 易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络投票的具体时间为：2024年 5月13日9:15-15:00期间的任意时间。 2、现场会议召开地点：江苏省南通市经济技术开发区通秀路29号3楼会议室 3、会议召开方式：现场表决与网络投票相结合的方式 4、会议召集人：公司董事会 5、会议主持人：董事长周军学先生 6、会议召开的合法合规 ...

北京市中伦（上海）律师事务所 关于昆山亚香香料股份有限公司 2023 年年度股东大会的 法律意见书 二〇二四年五月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 北京市中伦（上海）律师事务所 关于昆山亚香香料股份有限公司 2023 年年度股东大会的 法律意见书 致：昆山亚香香料股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《中华人民共和国证券 法》、《上市公司股东大会规则》及其他相关法律、法规、规章和规范性文件，以 及《公司章程》相关规定，北京市中伦（上海）律师事务所（下称"本所 ...

Investment Rating - The report maintains an "Outperform" investment rating for the company, with a target price of RMB 35.42, reflecting a 6% decrease from previous estimates [2][40]. Core Insights - The company's revenue for 2023 was RMB 630 million, a decline of 10.66% year-on-year, with a net profit attributable to shareholders of RMB 80 million, down 39.18% [7][10]. - The decrease in net profit was attributed to changes in downstream market demand and adjustments in product mix, with revenue from synthetic flavors, cooling agents, and natural flavors changing by -18.18%, 19.29%, and -29.53% respectively [7][11]. - The company is expanding its capacity and developing new products, with significant projects underway, including a 300-ton/year Isoamyl Acetate project and a 500-ton/year WS-23 project [7][11]. Financial Performance - The company's gross profit margin (GPM) for synthetic flavors, cooling agents, and natural flavors changed by -9.37, 1.50, and -5.05 percentage points, resulting in GPMs of 16.92%, 33.94%, and 37.20% respectively [7][11]. - Total expenses in sales, management, finance, and R&D increased significantly, with total expense ratio rising by 4.78 percentage points to 19.18% [7][11]. - The projected earnings per share (EPS) for 2024, 2025, and 2026 are RMB 1.54, RMB 2.55, and RMB 3.25 respectively, indicating a recovery in profitability [2][40]. Revenue and Cost Projections - The total revenue is expected to grow to RMB 900 million in 2024, RMB 1.199 billion in 2025, and RMB 1.438 billion in 2026, with corresponding net profits of RMB 124 million, RMB 206 million, and RMB 262 million [6][12]. - The gross profit margin is projected to improve to 33.7% in 2024, 35.7% in 2025, and 37.2% in 2026 [6][12]. Market Position and Competitive Advantage - The company has established strong relationships with well-known domestic and international firms, leveraging its advantages in brand, customer resources, product quality, and technology [11][7]. - As an early developer of natural flavors in China, the company has a robust R&D and production capability, currently able to mass-produce nearly 300 types of flavors, including over 160 natural flavors [11][7].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price adjusted to 37.15 yuan from the previous 38.25 yuan [7][13][18]. Core Views - The company is expected to see a performance turnaround in 2024, with anticipated revenue growth and improved profitability metrics. The report highlights that the company's revenue for 2023 is projected at 630 million yuan, a year-on-year decrease of 10.66%, while the net profit is expected to be 80 million yuan, down 39.18% year-on-year [7][13][18]. - The report emphasizes the company's strong market position in the flavor and fragrance industry, particularly with its natural flavor products, which accounted for 91.23% of gross profit in 2023, up from 87.11% in 2022 [7][13][18]. - The upcoming production capacity from the Thailand base is expected to enhance the company's global footprint and operational efficiency, with plans for further expansion in the flavor and fragrance product lines [7][13][18]. Financial Summary - The company's total revenue for 2022 was 705 million yuan, with a projected increase to 837 million yuan in 2023 and further growth to 1,027 million yuan in 2024 [7][13]. - The EBIT for 2023 is forecasted at 138 million yuan, with a significant recovery expected in 2024 to 194 million yuan [7][13]. - The net profit margin is projected to improve in 2024, with a net profit of 130 million yuan, reflecting a recovery from the previous year's decline [7][13]. Operational Metrics - The report notes a decrease in operating expenses, contributing to an improved net profit margin of 10.11% in Q1 2024, compared to the previous quarter [7][13]. - The company's return on equity (ROE) is expected to recover to 7.9% in 2024, up from 5.1% in 2023 [7][13]. - The report highlights the company's strong cash flow management, with a projected free cash flow of 194 million yuan in 2024, a significant turnaround from a negative cash flow in 2023 [7][13].

Investment Rating - The report maintains an "Outperform" rating for the company [22] Core Views - The company's 2023 net profit attributable to shareholders was 80 million yuan, a year-on-year decrease of 39.18%, attributed to changes in overall downstream market demand and adjustments in product structure [24] - The company is optimistic about its Thailand base becoming a new growth point for performance [24] - Revenue from synthetic flavors, cooling agents, and natural flavors in 2023 showed changes of -18.18%, 19.29%, and -29.53%, respectively [24] - The gross profit margins for synthetic flavors, cooling agents, and natural flavors in 2023 changed by -9.37, 1.50, and -5.05 percentage points, respectively [24] Financial Forecasts - The company expects earnings per share (EPS) for 2024, 2025, and 2026 to be 1.54, 2.55, and 3.25 yuan, respectively [20] - Total revenue is projected to increase from 630 million yuan in 2023 to 900 million yuan in 2024, and further to 1.44 billion yuan in 2026 [21] - The gross profit margin is expected to improve from 32.2% in 2023 to 37.2% in 2026 [21] Business Expansion and Product Development - The company is actively expanding production capacity and continuously developing new products and processes [19] - The Thailand production base's first phase is expected to produce 1,000 tons of vanillin, 200 tons of moss extract, and other products, aiming for production by December 31, 2024 [19] - The company has established stable business relationships with many well-known domestic and international companies, leveraging its brand and customer resource advantages [25]

Financial Performance - The company's revenue for Q1 2024 was CNY 174,061,189.54, representing a 39.41% increase compared to CNY 124,853,648.63 in the same period last year[5]. - Net profit attributable to shareholders decreased by 13.55% to CNY 17,796,689.08 from CNY 20,585,647.38 year-on-year[5]. - The company reported a 13.28% increase in net profit attributable to shareholders after deducting non-recurring gains and losses, reaching CNY 17,301,162.95 compared to CNY 15,272,758.20 last year[5]. - The company's basic and diluted earnings per share decreased by 12.00% to CNY 0.22 from CNY 0.25 in the same period last year[5]. - The total operating revenue for Q1 2024 was CNY 174,061,189.54, an increase of 39.4% compared to CNY 124,853,648.63 in the same period last year[24]. - Net profit decreased to ¥17,595,543.39 from ¥20,613,180.92, a decline of about 14.8% compared to the previous year[26]. - Operating profit was ¥20,403,727.42, down from ¥22,647,052.93, reflecting a decrease of approximately 9.9% year-over-year[25]. - The total comprehensive income attributable to the parent company was ¥8,384,635.48, down from ¥20,147,047.60, a decrease of approximately 58.3%[26]. Cash Flow and Operating Activities - The net cash flow from operating activities fell by 53.17% to CNY 7,788,178.44, down from CNY 16,631,524.12 in the previous year[5]. - Cash flow from operating activities generated a net amount of ¥7,788,178.44, down from ¥16,631,524.12, a decline of about 53.2%[29]. - The company’s cash and cash equivalents at the end of Q1 2024 amounted to CNY 374,019,600.11, up from CNY 325,081,910.91 at the beginning of the quarter, reflecting a growth of 15.1%[20]. - Cash and cash equivalents at the end of the period increased to ¥353,877,493.72 from ¥199,988,320.51, an increase of approximately 77.2% year-over-year[30]. Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 1,856,869,207.78, a 0.96% increase from CNY 1,839,185,281.42 at the end of the previous year[5]. - The total liabilities increased to CNY 276,407,529.63 from CNY 261,901,071.64, marking a rise of 5.5%[22]. - The non-current assets totaled CNY 819,733,562.10, up from CNY 712,385,518.18, reflecting an increase of 15.0%[22]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 5,059[11]. - The largest shareholder, Zhou Junxue, holds 39.93% of the shares, totaling 32,261,951 shares[11]. - The second-largest shareholder, Kunshan Dinglong Bohui Investment Management Enterprise, holds 6.86% of the shares, totaling 5,541,800 shares[11]. - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, with the largest three shareholders alone holding over 50%[11]. - The company has a total of 3,112,388 restricted shares held by Kunshan Dinglong Bohui Investment Management Enterprise, which will be released on January 5, 2024[15]. - The company reported a total of 1,536,200 shares held by Shanghai Xuanding Asset Management Co., Ltd. through a private equity fund[12]. - The total number of shares held by the top 10 unrestricted shareholders is 5,541,800 shares[12]. - The company has a total of 2,079,769 shares held by the Industrial and Commercial Bank of China through a flexible allocation mixed securities investment fund[11]. Operating Costs and Expenses - The company reported a 58.24% increase in operating costs, amounting to CNY 127,689,673.69, due to increased revenue[9]. - Total operating costs increased to ¥152,131,921.38 from ¥109,717,820.17, representing an increase of approximately 38.4% year-over-year[25]. - The company’s tax expenses increased to ¥2,192,987.53 from ¥1,996,814.23, reflecting an increase of about 9.8% year-over-year[25]. - The company reported a decrease in employee compensation payable from CNY 8,202,371.58 to CNY 4,843,847.30, a reduction of 41.5%[22]. Investment Activities - The company experienced a significant increase in prepayments, which rose by 155.85% to CNY 8,309,793.12, primarily due to increased advance payments for raw materials[9]. - The company’s investment activities generated a net cash outflow of CNY 17,855,021.09, a 136.96% decrease compared to the previous year, mainly due to increased investments in subsidiaries[9]. - Investment activities resulted in a net cash outflow of ¥17,855,021.09, compared to a net inflow of ¥48,304,955.36 in the previous year[29]. Strategic Developments - The company has not disclosed any new strategies or market expansions in the current reporting period[14]. - The company approved a restricted stock incentive plan to grant a total of 872,900 shares, which is 1.08% of the total share capital[17]. - The company plans to issue shares to specific investors through a simplified procedure, as approved in the board meeting[18].

昆山亚香香料股份有限公司 募集资金年度存放与使用情况专项报告 昆山亚香香料股份有限公司 关于募集资金年度存放与使用情况的专项报告 根据深圳证券交易所《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》及《深圳证券交易所创业板上市公司自律监管指南第 2 号——公告格 式》的规定，将昆山亚香香料股份有限公司（以下简称公司）2023 年度募集资金存放与 使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于同意昆山亚香香料股份有限公司首次公开发行股 票注册的批复》（证监许可〔2022〕892 号）核准，并经深圳证券交易所同意，公司首 次向社会公众发行人民币普通股（A 股）股票 2,020.00 万股，每股面值人民币 1.00 元， 发行价格为人民币 35.98 元/股，募集资金总额为人民币 726,796,000.00 元，扣除发行费 用人民币 64,701,898.50 元（不含税）后，实际募集资金净额为人民币 662,094,101.50 元。 上述募集资金已划至公司指定账户，容诚会计师事务所（特殊普通合伙）已于 2022 年 6 ...

证券代码：301220 证券简称：亚香股份 公告编号：2024-021 昆山亚香香料股份有限公司 关于 2024 年度董事、监事及高级管理人员薪酬方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 昆山亚香香料股份有限公司（以下简称"公司"）于 2024 年 4 月 18 日召开第三 届董事会第十六次会议，审议通过了《关于 2024 年度董事薪酬方案的议案》、《关于 2024 年度高级管理人员薪酬方案的议案》，并于同日召开第三届监事会第十四次会议， 审议通过了《关于 2024 年度监事薪酬方案的议案》，独立董事对董事、高级管理人员 薪酬方案发表了明确同意意见，董事和监事薪酬方案尚需提交公司股东大会审议。 为进一步完善公司的激励及约束机制，有效调动公司董事、监事及高级管理人员 的工作积极性，提高公司经营管理水平，确保公司战略目标的实现，经公司董事会薪 酬与考核委员会提议，同时结合公司实际情况和行业薪酬水平，制定了公司 2024 年 度董事、监事及高级管理人员薪酬方案。方案具体内容如下： 一、适用对象 公司董事、监事及高级管理人员。 二、生效条件及适用期限 ...

董事会审计委员会对会计师事务所 2023 年度履职情况评估及履行监督职责情况的报告 昆山亚香香料股份有限公司 董事会审计委员会对会计师事务所 2023 年度履职情况评估 及履行监督职责情况的报告 并出具了专项报告。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办法》和昆山亚香香料股份有限公 司（以下简称"公司"）的《公司章程》《董事会审计委员会工作细则》等规定和要 求，董事会审计委员会本着勤勉尽责的原则，恪尽职守，认真履责。现将董事会审计 委员会对会计师事务所 2023 年度履职评估及履行监督职责的情况汇报如下： 一、2023 年年审会计师事务所基本情况 （一）会计师事务所基本情况 容诚会计师事务所（特殊普通合伙）（以下简称"容诚"）由原华普天健会计师 事务所（特殊普通合伙）更名而来，初始成立于 1988 年 8 月，2013 年 12 月改制为特 殊普通合伙企业，注册地址为北京市西城区阜成门外大街 22 号 1 幢外经贸大厦 901-22 至 901-26，首席合伙人肖厚发。容诚具有 A 股证券期货相关业务审计资质。截至 2023 年 1 ...

2、股东大会会议召集人：公司董事会 3、会议召开的合法、合规性： 证券代码：301220 证券简称：亚香股份 公告编号：2024-030 昆山亚香香料股份有限公司 关于召开 2023 年年度股东大会的通知公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、本次召开股东大会的基本情况 1、股东大会届次：2023 年年度股东大会 （1）公司第三届董事会第十六次会议于 2024 年 4 月 18 日召开，审议通过了《关 于召开 2023 年年度股东大会的议案》。 （2）本次股东大会的召开符合《公司法》、《证券法》、《深圳证券交易所创业 板股票上市规则》等有关法律、行政法规、部门规章、规范性文件和《昆山亚香香料 股份有限公司章程》（以下简称"《公司章程》"）的有关规定。 4、股东大会现场会议召开时间： （1）现场会议：2024 年 5 月 13 日（星期一）14:00（参加现场会议的股东请于 会前 15 分钟到达开会地点，办理登记手续）。 （2）网络投票时间：2024 年 5 月 13 日 ①通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投票的具体时 ...